Gilead Sciences Inc 

GILD:NASDAQ

LastChange / % ChangeDividend YieldVolumeAvg Volume (10 day)
56.36 0.00   0.00%0.00%014.2M

Market data is delayed by at least 20 minutes.

 
 
 
 
 
 
 
 
 
5/16/2013 7:18 AM ET
Market ComparisonP/E (TTM)P/E (Forward
12 Months)
PEG1 Year EPS
Growth Rate
5 Year EPS
Growth Rate
GILD
Gilead Sciences Inc
37.428.01.5-7.70%14.79%
Biotechnology & Drugs
Industry
53.016.13.311.30%8.20%
Healthcare
Sector
25.117.84.0-49.14%6.88%
S&P; 50017.819.13.5-3.39%6.33%

Earnings Summary

On 5/2/2013, GILD reported 1 quarter 2013 earnings of $0.48 per share. This result was in-line with the consensus of the 23 analysts following the company and beat last year's 1 quarter results by 5.49%.

The next earnings announcement is expected on 07/22/2013.

GILD's PE ratio is among the highest of any stock in the Biotechnology & Drugs industry and signals that investors have high hopes for this company's future business prospects. However, during the past year, earnings growth has lagged its historical five year growth rate.